Jennifer L Wilkinson-Berka Selected Research

Protective Agents

1/2015

FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jennifer L Wilkinson-Berka Research Topics

Disease

20	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2023 - 01/2004
19	Retinopathy of Prematurity (Retrolental Fibroplasia) 10/2023 - 03/2003
13	Inflammation (Inflammations) 10/2023 - 01/2004
9	Hypoxia (Hypoxemia) 01/2020 - 03/2003
8	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023 - 01/2002
8	Hypertension (High Blood Pressure) 10/2019 - 01/2003
7	Pathologic Neovascularization 01/2023 - 01/2006
6	Retinal Neovascularization 10/2023 - 01/2006
6	Vascular System Injuries 10/2023 - 01/2013
6	Ganglion Cysts (Ganglion) 11/2017 - 09/2003
5	Gliosis 01/2023 - 01/2013
4	Hyperoxia 10/2023 - 03/2003
4	Vascular Diseases (Vascular Disease) 01/2023 - 07/2010
4	Retinal Diseases 07/2015 - 01/2010
4	Diabetes Complications 07/2015 - 01/2004
4	Fibrosis (Cirrhosis) 07/2004 - 01/2003
4	Albuminuria 01/2004 - 03/2002
3	Eye Diseases (Eye Disease) 01/2020 - 08/2005
2	Leukostasis 01/2015 - 01/2009
1	Bronchopulmonary Dysplasia 01/2020
1	Lung Injury 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2020
1	Central Serous Chorioretinopathy 10/2019
1	Experimental Diabetes Mellitus 11/2018
1	Aortic Rupture 01/2018
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2018
1	Aneurysm (Aneurysms) 01/2018
1	Kidney Diseases (Kidney Disease) 01/2016
1	Acute Lung Injury 01/2016
1	Ischemia 07/2015
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2015

Drug/Important Bio-Agent (IBA)

30	Retinaldehyde (Retinal)IBA 10/2023 - 03/2003
15	Oxygen (Dioxygen)IBA 10/2023 - 03/2003
13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 09/2003
10	Angiotensin IIIBA 10/2019 - 11/2002
9	Messenger RNA (mRNA)IBA 01/2016 - 09/2003
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2002
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 07/2015
7	ReninIBA 05/2015 - 02/2003
6	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2023 - 06/2010
6	Streptozocin (Streptozotocin)FDA Link 08/2005 - 03/2002
5	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2023 - 01/2009
5	AntioxidantsIBA 01/2018 - 01/2013
5	AngiotensinsIBA 01/2010 - 01/2004
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 03/2012
4	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2015
4	Protein Isoforms (Isoforms)IBA 01/2020 - 05/2013
4	Valsartan (Vals)FDA Link 01/2020 - 02/2007
4	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020 - 06/2014
4	AldosteroneIBA 10/2019 - 01/2009
4	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2015 - 01/2009
3	CytokinesIBA 01/2023 - 01/2015
3	setanaxibIBA 01/2018 - 06/2014
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 01/2002
3	Transforming Growth Factor beta (TGF-beta)IBA 02/2003 - 01/2002
2	Type 1 Angiotensin ReceptorIBA 01/2020 - 03/2012
2	Spironolactone (Aldactone)FDA LinkGeneric 01/2020 - 01/2009
2	Chemotactic FactorsIBA 01/2020 - 03/2012
2	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2020 - 03/2012
2	FadrozoleIBA 01/2020 - 03/2012
2	CollagenIBA 01/2018 - 03/2002
2	Glutathione (Reduced Glutathione)IBA 07/2015 - 01/2013
2	Oxidoreductases (Dehydrogenase)IBA 07/2015 - 03/2012
2	Prorenin ReceptorIBA 05/2015 - 07/2009
2	Advanced Glycation End ProductsIBA 11/2013 - 12/2010
2	candesartanIBA 12/2010 - 07/2004
2	Insulin-Like PeptidesIBA 01/2006 - 08/2005
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2004 - 03/2002
1	Peroxidase (Myeloperoxidase)IBA 10/2023
1	finerenoneIBA 01/2023
1	Mineralocorticoid Receptor AntagonistsIBA 01/2023
1	Chemokine ReceptorsIBA 01/2023
1	Granzymes (Granzyme)IBA 01/2023
1	Interferon-gamma (Interferon, gamma)IBA 01/2023
1	PerforinIBA 01/2023
1	Superoxides (Superoxide)IBA 01/2020
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2020
1	InterferonsIBA 01/2020
1	BQ 788IBA 11/2018
1	Endothelins (Endothelin)IBA 11/2018
1	Antihypertensive Agents (Antihypertensives)IBA 11/2018
1	cyclo(Trp-Asp-Pro-Val-Leu)IBA 11/2018
1	Apolipoproteins E (ApoE)IBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	Endothelin-2IBA 01/2018
1	AutoantigensIBA 01/2018
1	Matrix Metalloproteinase 12IBA 01/2018
1	2- (2- chlorophenyl)- 4- methyl- 5- (pyridin- 2- ylmethyl)- 1H- pyrazolo(4,3- c)pyridine- 3,6(2H,5H)- dioneIBA 01/2018
1	SR1001IBA 01/2016
1	Digoxin (Digitek)FDA LinkGeneric 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Interleukin-17 (Interleukin 17)IBA 01/2016
1	Vascular Endothelial Growth Factor DIBA 01/2016
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2016
1	CalciumIBA 07/2015
1	Glial Fibrillary Acidic ProteinIBA 07/2015
1	ebselenIBA 07/2015
1	dihydroethidiumIBA 07/2015
1	Glutamate-Cysteine LigaseIBA 07/2015

Therapy/Procedure

1	Intravitreal Injections 11/2018